ALV Form 4: Frederic Lissalde Granted RSUs, Vesting by 2026
Rhea-AI Filing Summary
Frederic Lissalde, a director of Autoliv Inc. (ALV), reported receipt of restricted stock units (RSUs) on 09/23/2025. The Form 4 shows an award described as "Restricted Stock Unit (1)" with a reported transaction quantity of 11.5121 (recorded as acquired at a price of $0) and a post-transaction beneficial ownership total of 1,728.5767 shares. The filing notes each RSU converts to one share and that dividend equivalents accrue as additional RSUs per the award agreement. The RSUs vest and convert in one installment on the earlier of Autoliv's 2026 annual meeting or the one-year anniversary of May 8, 2025.
Positive
- Director equity award disclosed: Report shows acquisition of RSUs on 09/23/2025 with 11.5121 recorded as acquired at $0.
- Post-transaction beneficial ownership explicitly stated as 1,728.5767 shares.
- Dividend equivalents included: Cash dividends on or after grant date accrue as additional RSUs per the award agreement.
Negative
- None.
Insights
TL;DR: Director reported a compensation grant of RSUs increasing beneficial ownership to 1,728.5767 shares.
The Form 4 documents an equity compensation grant to a director rather than an open-market purchase or sale, showing acquisition of RSUs on 09/23/2025 with a recorded quantity of 11.5121 and a post-transaction beneficial ownership of 1,728.5767 shares. The award includes dividend equivalent reinvestment and a single vesting/conversion event tied to the 2026 annual meeting or the one-year anniversary of May 8, 2025. For investors, this is a routine insider compensation disclosure and does not reflect a market transaction or change in control.
TL;DR: Routine director RSU grant with standard dividend-equivalent treatment and time-based vesting.
The filing specifies that dividend equivalents are paid as additional RSUs and that vesting/conversion occurs in a single installment on the earlier of the 2026 annual meeting or May 8, 2026 anniversary. This structure is consistent with typical director equity awards intended to align long-term interests, and the Form 4 properly discloses the quantity and timing. No departures from standard disclosure practice are evident within the submitted text.